High-density lipoprotein function in regulating insulin secretion: Possible relevance to metabolic syndrome

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 8, 2010, Pages 1497-1499

  Getz, Godfrey S ^a   Reardon, Catherine A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN; HIGH DENSITY LIPOPROTEIN; JANUS KINASE 2; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA;

DIABETES MELLITUS; DISEASE ASSOCIATION; EDITORIAL; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; ATP-BINDING CASSETTE TRANSPORTERS; CALCIUM; CHOLESTEROL; GLUCOSE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; KATP CHANNELS; KINETICS; LIPOPROTEINS; LIPOPROTEINS, HDL; METABOLIC SYNDROME X; MICE; RATS; SCAVENGER RECEPTORS, CLASS B; UP-REGULATION;

EID: 77955162881     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.110.210583     Document Type: Editorial

References (15)

1. Polonsky KS, Sturis J, Bell GI. Seminars in medicine of the Beth Israel Hospital, Boston non-insulin-dependent diabetes mellitus\a genetically programmed failure of the/3 cell to compensate for insulin resistance. N Engl J Med. 1996;334:777-783.
2. Kraegen EW, Cooney GJ. Free fatty acids and skeletal muscle insulin resistance. Curr Opin Lipidol. 2008;19:235-241.
3. Brunham LR, Kruit JK, Pape TD, Timmins JM, Reuwer AQ, Vasnji Z, Marsh BJ, Bodriques R, Johnson JD, Parks JS, Verchere CB, Hayden MR. B-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med. 2007;13:340-347.
4. Brunham LR, Kruit JK, Verchere B, Hayden MR. Cholesterol in islet dysfunction and type 2 diabetes. J Clin Invest. 2008;118:403-408.
5. Kruit JK, Brunham LR, Verchere CB, Hayden MR. HDL and LDL cholesterol significantly influence/3 cell function in type 2 diabetes. Curr Opin Lipidol. 2010;21:178-185.
6. Fryirs M, Barter PJ, Rye K-A. Cholesterol metabolism and pancreatic/3-cell function. Curr Opin Lipidol. 2009;20:159-164.
7. Xia F, Xie L, Mihic A, Chen Y, Gao X, Gaisano HY, Tsushima RG. Inhibition of cholesterol biosynthesis impairs insulin secretion and voltage gated calcium channel function in pancreatic/3 cells. Endocrinology. 2008; 149:5136-5145.
8. Fitzgerald ML, Morris AL, Chroni A, Mendez AJ, Zannis VI, Freeman MW. ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux. J Lipid Res. 2004; 45:287-294.
9. Fryirs MA, Barter PJ, Appavaroo M, Tuch BE, Tabet F, Heather AK, Rye K-A. Effect of high density lipoproteins on pancreatic/3 cell insulin secretion. Arterioscler Thromb Vasc Biol. 2010;30:1642-1648.
10. Tang C, Liu Y, Kessler PS, Vaughan AM, Oram JF. The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor. J Biol Chem. 2009;284:32336-32343.
11. Rütti S, Ehses JA, SiblerRA, PrazakR, Rohrer L, Georgopoulos S, Meier DT, Niclauss N, Berney T, Donath MY, von Eckardstein A. Low-and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic/3-cells. Endocrinology. 2009; 150:4521-4530.
12. Morioka T, Asilmaz E, Hu J, Dishinger JF, Kurpad AJ, Elias CF, Li H, Elmquist JK, Kennedy RT, Kulkamiu RN. Disruption of leptin receptor expression in the pancreas directly affects/3 cell growth and function in mice. J Clin Invest. 2007;117:2860-2868.
13. Haidar B, Denis M, Marcil M, Krimbou L, Genest J Jr. Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter. J Biol Chem. 2004;279:9963-9969.
14. Shao B, Pennathur S, Pagani I, Oda MN, Witztum JL, Oram JF, Heinecke JW. Dysfunctional HDL: modifying apolipoprotein A-I. by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the abca1 pathway. J Biol Chem. 2010; 285:18473-18484.
15. Passarelli M, Tang C, McDonald TO, O'Brien KD, Gerrity RG, Heinecke JW, Oram JF. Advanced glycation end product precursors impair ABCA1-dependent cholesterol removal from cells. Diabetes. 2005;54:2198-2205